[ET Net News Agency, 17 August 2021] WUXI BIO (02269) fell 5.45% to HK$114.4, dipping
below the 100-D SMA of HK$118.351.
It hits an intra-day low of HK$114.4, and an intra-day high of HK$122. The total shares
traded was 7.76 million, with a value of HK$912.86m. The active buy/sell ratio is 41:59,
with net selling turnover of HK$156.06m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$82.56m, with volume weighted average price of HK$117.622.
MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$62.19m, with
volume weighted average price of HK$117.621. The stock has fallen a combined 6.54% over
the past 2 consecutive trading days.
The Hang Seng Index now fell 42 points, or 0.16% to 26,139; the Hang Seng China
Enterprises Index now fell 27 points, or 0.29% to 9,238; the Hang Seng TECH Index now fell
42 points, or 0.66% to 6,377; with an overall turnover of HK$56.05b.
The SSE Composite Index now fell 2 points, or 0.07% to 3,514, with an overall turnover
of RMB284.3b.
The SZSE Component Index now rose 1 points, or 0.01% to 14,695, with an overall turnover
of RMB170.05b.
Basic Information
-------------------------------------------
Nominal 114.400 % Chg -5.45%
High 122.000 Low 114.400
Shares Tr 7.76m Turnover 912.86m
10-D SMA 123.900 %H.V 74.810
20-D SMA 123.435 VWAP 117.628
50-D SMA 129.140 RSI14 40.198
-------------------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 41:59, with net selling
turnover of HK$156.06m, falling a combined 6.54% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 114.40 -5.45
GENSCRIPT BIO (01548) 35.30 -0.14
INNOVENT BIO (01801) 72.70 +0.62
JXR (01951) 12.94 -0.15
JOINN (06127) 112.20 -1.84
BEIGENE (06160) 166.20 +1.34
CANSINOBIO-B (06185) 294.00 +0.34
AKESO-B (09926) 43.05 -1.37
INNOCARE-B (09969) 24.40 +5.86
REMEGEN-B (09995) 107.10 +2.49
-------------------------------------------------
(ed)